Patrizia Alessi

837 total citations
16 papers, 664 citations indexed

About

Patrizia Alessi is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Patrizia Alessi has authored 16 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Immunology and Allergy. Recurrent topics in Patrizia Alessi's work include Angiogenesis and VEGF in Cancer (6 papers), Biomarkers in Disease Mechanisms (5 papers) and Cell Adhesion Molecules Research (4 papers). Patrizia Alessi is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Biomarkers in Disease Mechanisms (5 papers) and Cell Adhesion Molecules Research (4 papers). Patrizia Alessi collaborates with scholars based in Italy, United States and Switzerland. Patrizia Alessi's co-authors include Marco Presta, Dario Neri, Daria Leali, Daniela Coltrini, Roberto Ronca, Arianna Giacomini, Luciano Zardi, Michela Corsini, Mirella Belleri and Doménico Ribatti and has published in prestigious journals such as Circulation Research, Brain and Biochemistry.

In The Last Decade

Patrizia Alessi

16 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrizia Alessi Italy 16 332 236 131 126 114 16 664
Shiro Kataoka Japan 13 480 1.4× 183 0.8× 219 1.7× 78 0.6× 103 0.9× 27 717
Zoia Levashova United States 15 293 0.9× 71 0.3× 92 0.7× 135 1.1× 111 1.0× 21 550
Gemma Shay United States 9 299 0.9× 105 0.4× 320 2.4× 52 0.4× 242 2.1× 10 637
Jessica L. Rennert United States 6 323 1.0× 103 0.4× 98 0.7× 35 0.3× 158 1.4× 7 618
Tina Zheng United States 4 305 0.9× 110 0.5× 158 1.2× 51 0.4× 159 1.4× 7 626
Ángel Santiago Mexico 9 697 2.1× 137 0.6× 325 2.5× 78 0.6× 261 2.3× 16 908
Jamie C. Stanford United States 8 509 1.5× 346 1.5× 533 4.1× 104 0.8× 181 1.6× 8 1.1k
Trevor Price United States 9 340 1.0× 140 0.6× 308 2.4× 31 0.2× 140 1.2× 21 849
Evelyn A. Kono United States 7 313 0.9× 119 0.5× 243 1.9× 51 0.4× 99 0.9× 11 635
Kym L. Stanley Australia 9 588 1.8× 107 0.5× 310 2.4× 45 0.4× 123 1.1× 10 893

Countries citing papers authored by Patrizia Alessi

Since Specialization
Citations

This map shows the geographic impact of Patrizia Alessi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrizia Alessi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrizia Alessi more than expected).

Fields of papers citing papers by Patrizia Alessi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrizia Alessi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrizia Alessi. The network helps show where Patrizia Alessi may publish in the future.

Co-authorship network of co-authors of Patrizia Alessi

This figure shows the co-authorship network connecting the top 25 collaborators of Patrizia Alessi. A scholar is included among the top collaborators of Patrizia Alessi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrizia Alessi. Patrizia Alessi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ronca, Roberto, Emanuela Di Salle, Arianna Giacomini, et al.. (2013). Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells. Molecular Cancer Therapeutics. 12(12). 2760–2771. 62 indexed citations
2.
Belleri, Mirella, Roberto Ronca, Daniela Coltrini, et al.. (2013). Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy. Brain. 136(9). 2859–2875. 32 indexed citations
3.
Ronca, Roberto, Patrizia Alessi, Daniela Coltrini, et al.. (2013). Long pentraxin‐3 as an epithelial–stromal fibroblast growth factor‐targeting inhibitor in prostate cancer. The Journal of Pathology. 230(2). 228–238. 59 indexed citations
4.
Leali, Daria, Patrizia Alessi, Daniela Coltrini, et al.. (2011). Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone–Regulated Tumors. Molecular Cancer Therapeutics. 10(9). 1600–1610. 46 indexed citations
5.
Ronca, Roberto, Patrizia Benzoni, Daria Leali, et al.. (2010). Antiangiogenic Activity of a Neutralizing Human Single-Chain Antibody Fragment against Fibroblast Growth Factor Receptor 1. Molecular Cancer Therapeutics. 9(12). 3244–3253. 26 indexed citations
6.
Alessi, Patrizia, et al.. (2009). Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. European Cytokine Network. 20(4). 225–234. 59 indexed citations
7.
Ronca, Roberto, Silvano Sozzani, Marco Presta, & Patrizia Alessi. (2009). Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case. Immunobiology. 214(9-10). 800–810. 22 indexed citations
8.
Caserta, Stefano, Patrizia Alessi, Veronica Basso, & Anna Mondino. (2009). IL‐7 is superior to IL‐2 for ex vivo expansion of tumour‐specific CD4+ T cells. European Journal of Immunology. 40(2). 470–479. 26 indexed citations
9.
Leali, Daria, Patrizia Alessi, Daniela Coltrini, et al.. (2009). Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides. Current Pharmaceutical Design. 15(30). 3577–3589. 27 indexed citations
10.
Belleri, Mirella, Doménico Ribatti, Monica Savio, et al.. (2008). αvβ3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. Molecular Cancer Therapeutics. 7(12). 3761–3770. 38 indexed citations
11.
Caserta, Stefano, Patrizia Alessi, Jlenia Guarnerio, Veronica Basso, & Anna Mondino. (2008). Synthetic CD4+ T Cell–Targeted Antigen-Presenting Cells Elicit Protective Antitumor Responses. Cancer Research. 68(8). 3010–3018. 17 indexed citations
12.
Wyss, Matthias T., Gregoire Biollaz, Jens Pahnke, et al.. (2007). Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 Gliomas and Correlation with 131I-SIP(L19), a Marker of Angiogenesis. Journal of Nuclear Medicine. 48(4). 608–614. 33 indexed citations
13.
Fabbrini, Monica, Eveline Trachsel, Stefano Bindi, et al.. (2005). Selective occlusion of tumor blood vessels by targeted delivery of an antibody‐photosensitizer conjugate. International Journal of Cancer. 118(7). 1805–1813. 56 indexed citations
14.
Heinis, Christian, Patrizia Alessi, & Dario Neri. (2004). Engineering a Thermostable Human Prolyl Endopeptidase for Antibody-Directed Enzyme Prodrug Therapy. Biochemistry. 43(20). 6293–6303. 30 indexed citations
15.
Matter, Christian M., Pia Schuler, Patrizia Alessi, et al.. (2004). Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin. Circulation Research. 95(12). 1225–1233. 79 indexed citations
16.
Alessi, Patrizia, et al.. (2003). Molecular targeting of angiogenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1654(1). 39–49. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026